Terrein induces apoptosis in HeLa human cervical carcinoma cells through p53 and ERK regulation

Oncology Reports

Volumn 29, Issue 4, 2013, Pages 1600-1608

  Porameesanaporn, Yuwarat ^a   Uthaisang Tanechpongtamb, Wanlaya ^b   Jarintanan, Faongchat ^c   Jongrungruangchok, Suchada ^d   Wongsatayanon, Benjamas Thanomsub ^a,b  

^a Departments of Microbiology   (South Korea)

^b SRINAKHARINWIROT UNIVERSITY   (Thailand)

^c Faculty of Medical Technology   (South Korea)

^d RANGSIT UNIVERSITY   (Thailand)

Author keywords

Apoptosis; Bax Bcl 2 ratio; Caspase 8Caspase 9; ERK2; P53; Terrein

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; DEATH RECEPTOR; HOE 33342; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; TERREIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL DEATH; CELL PROLIFERATION; CHROMATIN CONDENSATION; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG CYTOTOXICITY; DRUG DEVELOPMENT; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME SUBSTRATE; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; IC 50; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; UTERINE CERVIX CARCINOMA;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ASPERGILLUS; CARCINOMA; CELL PROLIFERATION; CYCLOPENTANES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOCHONDRIA; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 84874728121     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2288     Document Type: Article

References (42)

1. Jit M, Demarteau N, Elbasha E, Ginsberg G, Kim J, Praditsitthikorn N, Sinanovic E and Hutubessy R: Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models. BMC Med 54: 2-9, 2011.
2. Thomas GM: Improved treatment for cervical cancer-concurrent chemotherapy and radiotherapy. N Engl J Med 340: 1198-1200, 1999.
3. Ren G, Zhao YP, Yang L and Fu CX: Anti-proliferative effect of clitocine from the mushroom Leucopaxillus giganteus on human cervical cancer HeLa cells by inducing apoptosis. Cancer Lett 262: 190-200, 2008.
4. Park SJ, Wu CH, Gordon JD, Zhong X, Emami A and Safa AR: Taxol induces caspase-10-dependent apoptosis. J Biol Chem 279: 51057-51067, 2004.
5. Wang S, Konorev EA, Kotamraju S, Joseph J, Kalivendi S and Kalyanaraman B: Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. J Biol Chem 279: 25535-25543, 2004.
6. Day TW, Wu CH and Safa AR: Etoposide induces protein kinase Cd-and caspase-3 dependent apoptosis in neuroblastoma cancer cells. Mol Pharmacol 76: 632-640, 2009.
7. Tanida S, Mizoshita T, Ozeki K, Tsukamoto H, Kamiya T, Kataoka H, Sakamuro D and Joh T: Mechanisms of cisplatin-induced apoptosis and of cisplatin sensitivity: potential of BIN1 to act as a potent predictor of cisplatin sensitivity in gastric cancer treatment. Int J Surg Oncol 2012: 862879, 2012.
8. Newman DJ and Cragg GM: Microbial antitumor drugs: natural products of microbial origin as anticancer agents. Curr Opin Investig Drugs 10: 1280-1296, 2009.
9. Raistrick H and Smith G: Studies in the biochemistry of micro-organisms: the metabolic products of Aspergillus terreus Thom. A new mould metabolic product-terrein. Biochem J 29: 606-611, 1935.
10. Demasi M, Felicio AL, Pacheco AO, Leite HG, Lima C and Andrade LH: Studies on terrein as a new class of proteasome inhibitors. J Braz Chem Soc 21: 299-305, 2010.
11. Park SH, Kim DS, Kim WG, Ryoo IJ, Lee DH, Huh CH, Youn SW, Yoo ID and Park KC: Terrein: a new melanogenesis inhibitor and its mechanism. Cell Mol Life Sci 61: 2878-2885, 2004.
12. Kim DS, Lee S, Lee HK, Park SH, Ryoo IJ, Yoo ID, Kwon SB, Baek KJ, Na JI and Park KC: The hypopigmentary action of KI-063 (a new tyrosinase inhibitor) combined with terrein. J Pharm Pharmacol 60: 343-348, 2008.
13. Lee JC, Yu MK, Lee R, Lee YH, Jeon JG, Lee MH, Jhee EC, Yoo ID and Yi HK: Terrein reduces pulpal inflammation in human dental pulp cells. J Endod 34: 433-437, 2008.
14. Lee YH, Lee NH, Bhattarai G, Oh YT, Yu MK, Yoo ID, Jhee EC and Yi HK: Enhancement of osteoblast biocompatibility on titanium surface with Terrein treatment. Cell Biochem Funct 28: 678-685, 2010.
15. Kim DS, Lee HK, Park SH, Lee S, Ryoo IJ, Kim WG, Yoo ID, Na JI, Kwon SB and Park KC: Terrein inhibits keratinocyte proliferation via ERK inactivation and G2/M cell cycle arrest. Exp Dermatol 17: 312-317, 2007.
16. Arakawa M, Someno T, Kawada M and Ikeda D: A new terrein glucoside, a novel inhibitor of angiogenin secretion in tumor angiogenesis. J Antibiot 61: 442-448, 2008.
17. Liao WY, Shen CN, Lin LH, Yang YL, Han HY, Chen JW, Kuo SC, Wu SH and Liaw CC: Asperjinone, a nor-neolignan, and terrein, a suppressor of ABCG2-expressing breast cancer cells, from thermophilic Aspergillus terreus. J Nat Prod 75: 630-635, 2012.
18. Uthaisang W, Reutrakul V, Krachangchaeng C, Wilairat P and Fadeel B: VR-3848, a novel peptide derived from Euphobiaceae, induces mitochondria- dependent apoptosis in human leukemia cells. Cancer Lett 208: 171-178, 2004.
19. Oubrahim H, Stadtman ER and Chock PB: Mitochondria play no roles in Mn(II)-induced apoptosis in HeLa cells. Proc Natl Acad Sci USA 98: 9505-9510, 2001.
20. Feng Q, Cao HL, Xu W, Li XR, Ren YQ and Du LF: Apoptosis induced by genipin in human leukemia K562 cells: involvement of c-Jun N-terminal kinase in G2/M arrest. Acta Pharmacol Sin 31: 519-527, 2011.
21. Cossarizza A, Baccarani CM, Kalashnikova G and Franceschi C: A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5',6,6'-tetrachloro-1,1',3,3'- tetraethylbenzimidazolcar¬bocyanine iodide (JC-1). Biochem Biophys Res Commun 197: 40-45, 1993.
22. Gomez-Lazaro M, Galindo MF, Concannon CG, Segura MF, Fernandez-Gomez FJ, Llecha N, Comella JX, Prehn JH and Jordan J: 6-Hydroxydopamine activates the mitochondrial apoptosis pathway through p38 MAPK-mediated, p53-indepen¬dent activation of Bax and PUMA. J Neurochem 104: 1599-1612, 2008.
23. Puerto HLD, Martins AS, Milsted A, Souza-Fagundes EM, Braz GF, Hissa B, Andrade LO, Alves F, Rajão DS, Leite RC and Vasconcelos AC: Canine distemper virus induces apoptosis in cervical tumor derived cell lines. Virol J 334: 2-7, 2011.
24. Elmore S: Apoptosis: a review of programmed cell death. Toxicol Pathol 35: 495-516, 2007.
25. Ashkenazi A: Targeting the extrinsic apoptosis pathway in cancer. Cytokine Growth Factor Rev 19: 325-331, 2008.
26. Gu Q, Wang JD, Xia HHX, Lin MC, He H, Zou B, Tu SP, Yang Y, Liu XG, Lam SK, Wong WM, Chan AO, Yuen MF, Kung HF and Wong BC: Activation of the caspase-8/Bid and Bax pathways in aspirin-induced apoptosis in gastric cancer. Carcinogenesis 26: 541-546, 2005.
27. Budihardjo I, Oliver H, Lutter M, Luo X and Wang X: Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 15: 269-290, 1999.
28. Ghobrial IM, Witzig TE and Adjei AA: Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 55: 178-194, 2005.
29. Jin Z, Li Y, Pitti R, Lawrence D, Pham VC, Lill JR and Ashkenazi A: Cullin3-based polyubiquitination and p62-depen¬dent aggregation of caspase-8 mediate extrinsic apoptosis signaling. Cell 137: 721-735, 2009.
30. Kim SH, Kim SH, Lee SC and Song YS: Involvement of both extrinsic and intrinsic apoptotic pathways in apoptosis induced by genistein in human cervical cancer cells. Ann NY Acad Sci 1171: 196-201, 2009.
31. Hougardy BM, van der Zee AG, van den Heuvel FA, Timmer T, de Vries EG and de Jong S: Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relation¬ship with Fas, caspase-8, and Bid. Gynecol Oncol 97: 353-364, 2005.
32. Gross A, Jockel J, Wei MC and Korsmeyer SJ: Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J 17: 3878-3885, 1998.
33. Yang W, Gong X, Zhao X, An W, Wang X and Wang M: Capsaicin induces apoptosis in HeLa cells via Bax/Bcl-2 and caspase-3 pathways. Asian J Traditional Med 1: 3-4, 2006.
34. Mahfudh N and Pihie AHL: Eurycomanone induces apoptosis through the up-regulation of p53 in human cervical carcinoma cells. J Cancer Mol 4: 109-115, 2008.
35. Priyadarsini RV, Murugan RS, Maitreyi S, Ramalingam K, Karunagaran D and Nagini S: The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-?B inhibition. Eur J Pharmacol 649: 84-91, 2010.
36. Xu W, Liu J, Li C, Wu HZ and Liu YW: Kaempferol-7-O-ß-D-glucoside (KG) isolated from Smilax china L. rhizome induces G2/M phase arrest and apoptosis on HeLa cells in a p53-indepen¬dent manner. Cancer Lett 264: 229-240, 2008.
37. Wang X, Martindale JL and Holbrook NJ: Requirement for ERK activation in cisplatin-induced apoptosis. J Biol Chem 275: 39435-39443, 2000.
38. Yeh PY, Chuang SE, Yeh KH, Song YC, Chang LLY and Cheng AL: Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death. Oncogene 23: 3580-3588, 2004.
39. Wu Z, Wu LJ, Tashiro S, Onodera S and Ikejima T: Phosphorylated extracellular signal-regulated kinase up-regulated p53 expres¬sion in shikonin-induced HeLa cell apoptosis. Chin Med J 118: 671-677, 2005.
40. Singh M, Sharma H and Singh N: Hydrogen peroxide induces apoptosis in HeLa cells through mitochondrial pathway. Mitochondrion 7: 367-373, 2007.
41. Zhuang S and Schnellmann RG: A death-promoting role for extracellular signal-regulated kinase. J Pharmacol Exp Ther 319: 991-997, 2006.
42. Cagnol S and Chambard JC: ERK and cell death: mechanisms of ERK-induced cell death-apoptosis, autophagy and senescence. FEBS J 277: 2-21, 2010.